About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Congressman Scott Peters Tours Maravai’s RNA manufacturing facility

SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, recently hosted Congressman Scott Peters for a tour of the RNA manufacturing facility at Wateridge Circle in San Diego.

“We were honored to host Congressman Peters at our facility in San Diego,” said Carl Hull, Executive Chairman and Interim CEO of Maravai. “The active engagement of influential government officials such as Scott underscores a commitment to fostering innovation and growth in the life sciences community, in which Maravai is proud to play a leading role.”

Congressman Peters visited the Maravai Wateridge facility on the morning of June 2, and met with Carl Hull, Executive Chairman of the Board and Interim CEO of Maravai, and other members of the senior leadership team before touring the laboratories and conducting a question-and-answer session with Maravai employees. The focus of the visit was to highlight investment in research and development, promoting healthcare innovation, and to celebrate Maravai’s role in COVID vaccine production through the development of its proprietary CleanCap® mRNA capping technology and the future critical role that Maravai will play in U.S.-based pandemic preparedness.

“One of the most important aspects of my job serving California’s 50th district is engaging leading sectors I represent, including the life sciences and biotech fields,” said Rep. Peters. “I enjoyed speaking with Maravai leaders and employees recently who shared details on their work and research related to COVID-19 vaccine production. I thank them for their time and efforts to foster innovation in our community.”

Congressman Peters represents California’s 50th Congressional District, covering the cities of Coronado, San Marcos, Escondido and coastal San Diego. He was elected in 2012, and currently serves on the House Energy and Commerce Committee, the House Budget Committee and the House Equality Caucus. He previously served on the Energy & Commerce Committee and the Veteran’s Affairs Committee, and the House Committee on Science, Space, and Technology. As a former environmental attorney and Chairman of the Port of San Diego, Scott focuses on advancing practical and critical climate policies, and promoting and expanding San Diego’s innovation ecosystem.

About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics and cell and gene therapies companies.


Contact Information:
Media Contact: Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macdougall.bio 

Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.